Abiopharma

🔍 ROTHBLATT MARTINE A (Executive)

Company: UNITED THERAPEUTICS Corp (UTHR)

Report Date: 2026-08-14

Detailed Transactions and Holdings:

• Acquired 9,500 shares of Common Stock at $135.42 per share (Direct)
  Date: 2026-08-14 | Code: M | equity_swap_involved: false | shares_owned_after: 333,943.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 320 shares of Common Stock at $495.0232 per share (Direct)
  Date: 2026-08-14 | Code: S | equity_swap_involved: false | shares_owned_after: 333,623.00 | transaction_form_type: 4 | Footnotes: F1, F3, F2
• Sold 414 shares of Common Stock at $495.9648 per share (Direct)
  Date: 2026-08-14 | Code: S | equity_swap_involved: false | shares_owned_after: 333,209.00 | transaction_form_type: 4 | Footnotes: F1, F4, F2
• Sold 537 shares of Common Stock at $497.2192 per share (Direct)
  Date: 2026-08-14 | Code: S | equity_swap_involved: false | shares_owned_after: 332,672.00 | transaction_form_type: 4 | Footnotes: F1, F5, F2
• Sold 2,130 shares of Common Stock at $498.3942 per share (Direct)
  Date: 2026-08-14 | Code: S | equity_swap_involved: false | shares_owned_after: 330,542.00 | transaction_form_type: 4 | Footnotes: F1, F6, F2
• Sold 3,630 shares of Common Stock at $499.2963 per share (Direct)
  Date: 2026-08-14 | Code: S | equity_swap_involved: false | shares_owned_after: 326,912.00 | transaction_form_type: 4 | Footnotes: F1, F7, F2
• Sold 2,148 shares of Common Stock at $500.0459 per share (Direct)
  Date: 2026-08-14 | Code: S | equity_swap_involved: false | shares_owned_after: 324,764.00 | transaction_form_type: 4 | Footnotes: F1, F8, F2
• Sold 321 shares of Common Stock at $500.925 per share (Direct)
  Date: 2026-08-14 | Code: S | equity_swap_involved: false | shares_owned_after: 324,443.00 | transaction_form_type: 4 | Footnotes: F1, F9, F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-14 | Code: H | shares_owned_after: 40,513.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-14 | Code: H | nature_of_ownership: by Spouse | shares_owned_after: 166.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-14 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 249,108.00 | Footnotes: F10
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-14 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 45,596.00 | Footnotes: F11
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-14 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 8,902.00 | Footnotes: F12
• Sold 9,500 shares of Stock Option at $135.42 per share (Derivative)
  Date: 2026-08-14 | Code: M | Expires: 2027-03-15 | Exercise: 2023-03-15 | equity_swap_involved: false | shares_owned_after: 132,410.00 | transaction_form_type: 4 | Footnotes: F1, F13

Footnotes:

• F1: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.
• F10: Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
• F11: Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
• F12: Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
• F13: Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries.
• F2: Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
• F3: This transaction was executed in multiple trades at prices ranging from $494.61 to $495.33. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F4: This transaction was executed in multiple trades at prices ranging from $495.65 to $496.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F5: This transaction was executed in multiple trades at prices ranging from $496.71 to $497.69. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F6: This transaction was executed in multiple trades at prices ranging from $497.72 to $498.71. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F7: This transaction was executed in multiple trades at prices ranging from $498.73 to $499.70. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F8: This transaction was executed in multiple trades at prices ranging from $499.73 to $500.71. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F9: This transaction was executed in multiple trades at prices ranging from $500.82 to $501.14. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.